Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T04:00:42.211Z Has data issue: false hasContentIssue false

Interplay of combat deployment harassment, testosterone concentrations and post-deployment suicide risk in male veterans

Published online by Cambridge University Press:  26 March 2024

Leo Sher*
Affiliation:
James J. Peters VA Medical Center, New York, USA Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
Linda M. Bierer
Affiliation:
James J. Peters VA Medical Center, New York, USA Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
Janine Flory
Affiliation:
James J. Peters VA Medical Center, New York, USA Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
Iouri Makotkine
Affiliation:
James J. Peters VA Medical Center, New York, USA Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
Rachel Yehuda
Affiliation:
James J. Peters VA Medical Center, New York, USA Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
*
Corresponding author: Leo Sher; Email: Leo.Sher@mssm.edu
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Many combat veterans exhibit suicidal ideation and behaviour, but the relationships among experiences occurring during combat deployment and suicidality are still not fully understood. In this study, we tested the hypothesis that harassment during a combat deployment is associated with post-deployment suicidality and testosterone function.

Methods:

Male combat veterans who made post-deployment suicide attempts and demographically matched veterans without a history of suicide attempts were enrolled in the study. Demographic and clinical parameters of study participants were assessed and recorded. Study participants were interviewed by a trained clinician using the Mini-International Neuropsychiatric Interview (MINI), the Deployment Risk and Resilience Inventory (DRRI) – Relationships within unit scale, the Scale for Suicidal Ideation (SSI), and the Brown–Goodwin Aggression Scale. Free testosterone levels were assessed in morning blood samples.

Results:

DRRI harassment scores were higher and free testosterone levels were lower among suicide attempters in comparison with non-attempters. In the whole sample, DRRI harassment scores positively correlated with SSI scores and negatively correlated with free testosterone levels. Free testosterone levels negatively correlated with SSI scores. Aggression scale scores positively correlated with DRRI harassment scores among non-attempters but not among attempters.

Conclusion:

Our observations that harassment scores are associated with suicidality and testosterone levels, and suicidality is associated with testosterone levels may indicate that there is a link between deployment harassment, testosterone function and suicidality.

Information

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology
Figure 0

Table 1. Demographic and clinical features of combat veterans with or without a history of suicide attempts

Supplementary material: File

Sher et al. supplementary material

Sher et al. supplementary material
Download Sher et al. supplementary material(File)
File 14.9 KB